Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Hong Kong · Delayed Price · Currency is HKD

0.1880

+0.0100 (5.62%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sale of Imported Pharmaceutical Products		2.79B	2.51B	2.26B	2.02B	-
Sale of Imported Pharmaceutical Products Growth		11.08%	11.28%	11.62%	-	-
Medical Beauty Services		28.70M	25.93M	12.19M	-	-
Medical Beauty Services Growth		10.71%	112.65%	-	-	-
Sale of Human Albumin Solution, Antibiotics and Other Pharmaceutical Products		-	-	-	-	2.05B
Sale of Human Albumin Solution, Antibiotics and Other Pharmaceutical Products Growth		-	-	-	-	74.24%
Total		2.82B	2.54B	2.27B	2.02B	2.05B
Total Growth		11.07%	11.82%	12.23%	-1.26%	74.24%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China		2.82B	2.54B	2.27B	2.02B	2.05B
Mainland China Growth		11.07%	11.82%	12.23%	-1.26%	74.24%
Total		2.82B	2.54B	2.27B	2.02B	2.05B
Total Growth		11.07%	11.82%	12.23%	-1.26%	74.24%

Source: S&P Global Market Intelligence.